Importance of DNA Sequencing for Abnormal Hemoglobins Detected by HPLC Screening

Kaynakça (5)

1. Canatan D, Kose MR, Ustundağ M, Haznedaroglu D, Ozbaş S. Hemoglobinopathy control program in Turkey. Community Genet 2006;9:124-126
2. Canatan D, Delibas S. Report on ten years’ experience of premarital hemoglobinopathy screening at a center in Antalya, Southern Turkey. Hemoglobin 2016;40:273-276
3. Al-Madhani A, Pathare A, Al Zadjali S, Al Rawahi M, Al-Nabhani I, Alkindi S. The use of HPLC as a tool for neonatal cord blood screening of haemoglobinopathy: a validation study. Mediterr J Hematol Infect Dis 2019;11:e2019005
4. Warghade S, Britto J, Haryan R, Dalvi T, Bendre R, Chheda P, Matkar S, Salunkhe Y, Chanekar M, Shah N. Prevalence of hemoglobin variants and hemoglobinopathies using cation-exchange high-performance liquid chromatography in central reference laboratory of India: a report of 65779 cases. J Lab Physicians 2018;10:73-79
5. Chen GL, Qu YX, Jiang F, Tang Y, Tang F, Zuo LD. Screening abnormal hemoglobin diseases for couples of childbearing age in Guangzhou City by HPLC. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017;25:1768-1771.